The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase I Study of Paclitaxel (P) and Irinotecan (I) Coadministered Weekly in Patients with Advanced Cancers: Lymphopenia as a Principal Toxicity.
 
Yuma Wada
No Relationships to Disclose
 
Yuji Morine
No Relationships to Disclose
 
Satoru Imura
No Relationships to Disclose
 
Tetsuya Ikemoto
No Relationships to Disclose
 
Shuichi Iwahashi
No Relationships to Disclose
 
Yu Saito
No Relationships to Disclose
 
Hiroki Teraoku
No Relationships to Disclose
 
Shogo Ohta
No Relationships to Disclose
 
Jun Higashijima
No Relationships to Disclose
 
Mitsuo Shimada
Research Funding - Chugai Pharma (Inst); Taiho Pharmaceutical (Inst); TSUMURA & CO. (Inst); Yakult Honsha (Inst)